(19)
(11) EP 3 358 481 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
25.08.2021 Bulletin 2021/34

(45) Mention of the grant of the patent:
21.07.2021 Bulletin 2021/29

(21) Application number: 16850233.4

(22) Date of filing: 31.08.2016
(51) International Patent Classification (IPC): 
G16C 20/30(2019.01)
(86) International application number:
PCT/CN2016/097514
(87) International publication number:
WO 2017/054609 (06.04.2017 Gazette 2017/14)

(54)

COMBINED MEDICATION EFFICACY PROCESSING METHOD AND APPARATUS

VERFAHREN UND VORRICHTUNG ZUR VERARBEITUNG DER WIRKSAMKEIT EINER ARZNEIMITTELKOMBINATION

PROCÉDÉ ET APPAREIL DE TRAITEMENT DE L'EFFICACITÉ D'UN MÉDICAMENT COMBINÉ

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 30.09.2015 CN 201510640075

(43) Date of publication of application:
08.08.2018 Bulletin 2018/32

(73) Proprietor: Institute of Radiation Medicine, Academy of Military Medical Sciences, PLA.
Haidian District Beijing 100850 (CN)

(72) Inventors:
  • YUAN, Shoujun
    Beijing 100850 (CN)
  • LI, Linna
    Beijing 100850 (CN)
  • YANG, Dexuan
    Beijing 100850 (CN)

(74) Representative: Zacco Denmark A/S 
Arne Jacobsens Allé 15
2300 Copenhagen S
2300 Copenhagen S (DK)


(56) References cited: : 
WO-A2-2005/058373
CN-A- 101 339 584
CN-A- 105 224 799
US-A1- 2008 075 762
 CN-A- 101 046 831
CN-A- 102 269 755
US-A1- 2003 192 560
   
  • JULIE FOUCQUIER ET AL: "Analysis of drug combinations: current methodological landscape", PHARMACOLOGY RESEARCH & PERSPECTIVES, vol. 3, no. 3, 20 May 2015 (2015-05-20), pages 1-11, XP055462926, GB ISSN: 2052-1707, DOI: 10.1002/prp2.149
  • R. J. TALLARIDA: "Quantitative Methods for Assessing Drug Synergism", GENES & CANCER, vol. 2, no. 11, 1 November 2011 (2011-11-01), pages 1003-1008, XP055206103, ISSN: 1947-6019, DOI: 10.1177/1947601912440575
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).